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a  b  s  t  r  a  c  t
Bisphenol  A  (BPA)  is of global  concern  because  of its disruption  of endocrine  systems  and  ubiquity  in
aquatic  environment.  In  this  study,  BPA  antibody  was  successfully  immobilised  on  novel  mesoporous
silica  (MPS)  carriers  that  display  unique  properties  such  as  high  surface  area,  highly  uniform  pore  distribu-
tion and high  adsorption  capacity.  Mobil  Crystalline  Material  MCM-41  (2.7  nm),  Santa  Barbara  Amorphous
SBA-15-1  (12.3  nm)  and  SBA-15-2  (24.0  nm)  materials  were  used  as supports  for  these  antibodies.  On
these  carriers,  the BPA  antibody  immobilisation  reached  40  g mg−1. For  each  MPS,  15 ng of  BPA  antigen
was  adsorbed  on 1  mg  of  MPS–antibody  composite,  which  resulted  in  an  antibody  activity  of  30%.  Theisphenol A
esoporous silica
ore size
highest  recovery  rate  of  BPA  antigen  was observed  for 80%  acetonitrile  in 10  mM  phosphate  buffer  (pH
7). After  six repeated  runs,  BPA  antibodies  immobilised  on SBA-15-1  and  SBA-15-2  retained  about  30%
of  their  initial  activity.  In contrast,  these  antibodies  showed  13%  lower  residual  activity  on  MCM-41  than
on  SBA-15-1  and  SBA-15-2.  This  result  indicated  that  entire  antibody  molecules  were adsorbed  inside
SBA-15-1  and SBA-15-2  pores,  stabilising  their structural  conformation.
© 2014 The  Ceramic  Society  of  Japan  and  the Korean  Ceramic  Society.  Production  and  hosting  by. Introduction
Mesoporous silica (MPS) has attracted considerable research
nterest since Mobil ﬁrst proposed its use in 1992 [1]. In addition
o being easily functionalisable, this material has exhibited stability
or synthesis, high and speciﬁc surface areas and pore volumes [2,3],
ell-deﬁned channels, hydrothermal stability [4], adjustable pore
izes [5] and narrow size distribution [6]. Therefore, MPS  can ﬁnd
pplications in adsorption materials [7–9], catalyst carriers [10–12]
nd separation sensors [13,14]. In addition, its implementation in
iological applications, such as drug delivery [15], transfection and
egenerative medicine [16], is expected.
The immobilisation of enzymes, antibodies and other proteins
n solid supports that can improve the biological stability and∗ Corresponding author at: 2266-98, Anagahora, Shimoshidami, Moriyama,
agoya 463-8560, Japan. Tel.: +86 52 736 7551; fax: +86 52 736 7405.
E-mail address: katsuya-kato@aist.go.jp (K. Kato).
eer review under responsibility of The Ceramic Society of Japan and the Korean
eramic Society.
187-0764 © 2014 The Ceramic Society of Japan and the Korean Ceramic Society.
roduction and hosting by Elsevier B.V. All rights reserved.
ttp://dx.doi.org/10.1016/j.jascer.2014.05.010Elsevier  B.V.  All  rights  reserved.
activity under extreme conditions has proven quite useful for catal-
ysis, sensing and separation applications [17–19]. The creation
of MPS-based high-performance biosensors and protein separa-
tion systems hinges on a better understanding of the factors that
inﬂuence the pore size and morphology in these materials. Nakan-
ishi et al. [20] have previously described the relationship between
protein A molecules and MPS  pore sizes, as well as the reusabil-
ity of antibodies immobilised on MPS. They observed that the
MPS-immobilised protein A showed higher binding activity to the
antigen (IgG) on MPSs with a smaller pore size (2.7 nm). Inter-
estingly, 8-anilino-1-naphthalenesulphonic acid (ANS) analysis
indicated that conformational changes during the immobilisation
process did not impact IgG binding activity. These ﬁndings sug-
gested that the optimisation of MPS  pore size was  extremely
important for protein A immobilisation [21–23].
Often present in environmental water, bisphenol A [2,2-bis(4-
hydroxyphenyl)propane, BPA] has now drawn attention because
of its harmful effects on the endocrine systems of humans and
wild animals [24–27]. Widely used for the production of epoxy
resins and polycarbonate plastics [28], this endocrine disrupter
is currently found in baby bottles, plastic drinking bottles, dental
seals, injection syringes, canned beverage drinks and metal food
containers. Several methods based on high-performance liquid
chromatography (HPLC) and gas chromatography/mass spectrom-
etry (GC/MS) [29–31] have been developed for the characterisation
of BPA. However, these methods are required to elaborate pretreat-
ments [32,33]. Trace amounts of BPA have also shown estrogenic
2  Ceram
a
t
n
w
c
w
t
B
n
i
o
a
t
a
t
i
i
s
t
o
b
2
2
a
o
(
S
(
w
T
C
w
B
B
i
p
2
2
C
a
t
2
w
w
t
6
2
[
3
g
m
N
a
t
trifuged and the unbound antigen present in the supernatant was
isolated and analysed by high-performance liquid chromatography
(HPLC). HPLC was performed using a Shimadzu LC 10-AD instru-
ment equipped with an ultraviolet detector set at 210 nm and a76 T. Orita et al. / Journal of Asian
ctivity even at concentrations as low as 0.001 ng mL−1 [34–36]. In
his ultra-low concentration range, many factors, such as contami-
ation from glasswares, containers and injection syringes, interfere
ith BPA characterisation. Furthermore, puriﬁed water contains
ertain BPA levels as a result of leaching from resin parts in the
ater puriﬁcation system. Therefore, effective methods to concen-
rate and to detect low BPA concentrations need to be developed.
ecause of their highly uniform channels, large surface area and
arrow pore-size distribution, MPS  supports are expected to be
deal sensing materials for enhancing the stability and sensitivity
f BPA detection.
To the best of our knowledge, few comparative studies have
ddressed the adsorption of BPA antibody onto MPS, and its applica-
ion to microanalysis. In this study, various MPSs were used as BPA
ntibody carriers and their activity was evaluated. Organic solvent-
olerance and recyclability of the MPS  immobilised antibody were
nvestigated because pore size plays a pivotal role in determin-
ng the immobilisation state of antibodies which is related to the
tability of antibodies.
The enhanced antibody stability and activity upon immobilisa-
ion on optimal MPS  carriers will be advantageous in a wide range
f industrial scale applications such as microanalysis systems and
iosensors.
. Experimental
.1. Materials
All the materials were of analytical grade and were used
s received from the manufacturer. The triblock poly(ethylene
xide)–poly(propylene oxide)–poly(ethylene oxide) copolymer
Pluronic P123, Mw  = 5800, EO20PO70EO20) was purchased from
igma–Aldrich (St. Louis, MO). Cetyltrimethylammonium bromide
CTAB, [CH3(CH2)15N(CH3)3]Br) and 1,3,5-trimethylbenzene (TMB)
ere procured from Wako Pure Chemical Industries (Tokyo, Japan).
etraethoxysilane (TEOS) was obtained from Shin-Etsu Chemical
o. (Tokyo, Japan). The protein-free blocking buffer (No. 37570)
as acquired from Thermo Fisher Scientiﬁc Inc. (Waltham, MA).
isphenol A was  obtained from Kanto Chemical Co. (Tokyo, Japan).
isphenol A polyclonal antibody was gifted by Japan EnviroChem-
cals (Osaka, Japan). The Bio-Rad Protein Assay Kit (500-0006) was
urchased from Bio-Rad Laboratories (Hercules, CA).
.2. Synthesis of mesoporous silica materials
.2.1. Synthesis of Mobil Crystalline Material MCM-41
MCM-41 was synthesised using CTAC as an organic template.
TAB (2.6 g) was added to an aqueous HCl solution (pH 0.5, 30 mL)
nd stirred for 2 h at room temperature. TEOS (3.5 g) was  added to
he solution and the mixture was stirred for 5 h. Ammonia (3.0 g,
8 wt%, 14.7 M)  was added at one time. After standing for 24 h, the
hite precipitate was ﬁltered, successively washed with deionised
ater (50 mL)  and ethanol (50 mL)  and dried overnight at room
emperature. Finally, the sample was calcined at 500 ◦C in air for
 h (heating rate: 1 ◦C min−1) to remove the organic template.
.2.2. Synthesis of Santa Barbara Amorphous SBA-15-1
SBA-15-1 was synthesised using P123 as an organic template
37,38]. P123 (1 g) was dissolved in 1.07 M hydrogen chloride (HCl,
5 mL)  and the solution was stirred for 2 h at room temperature to
ive SBA-15-1. n-Decane (7.6 g) was added to the solution and the
ixture was stirred for 2 h at room temperature. After addition of
H4F (11.5 mg)  and TEOS (2.13 g), the solution was  stirred for 1 h
t room temperature and kept at 40 ◦C for 20 h using a tempera-
ure controlled bath. The solid product was collected by ﬁltration,ic Societies 2 (2014) 275–280
washed and dried overnight at room temperature. Organic tem-
plate removals by calcination were performed through the same
procedure as for MCM-41.
2.2.3. Synthesis of SBA-15-2
P123 (1 g) was  dissolved in 1.07 M HCl (35 mL)  and the solution
was stirred for 2 h at room temperature. The solution was rapidly
mixed with TMB  (5 g) to expand pore sizes and the mixture was
stirred for 3 d at 25 ◦C [39]. NH4F (11.5 mg)  and TEOS (2.1 g) were
successively added to the mixture which was stirred for 1 h at room
temperature. The resulting solution was further stirred at 40 ◦C in
a temperature controlled bath for 24 h before being transferred to
an autoclave and heated at 100 ◦C for 48 h. The solid product was
collected by ﬁltration, washed and dried at 70 ◦C for 5 h. P123 and
TMB  were removed by calcination using a procedure similar to that
used for MCM-41.
2.3. Material characterisation
The speciﬁc surface area and pore volume of materials were
measured by gas adsorption following the Brunauer–Emmett–
Teller (BET) method using a Tristar3000 micrometrics analyser
(Shimazu Co., Kyoto, Japan). Small-angle X-ray diffraction (XRD)
spectra were recorded using a Rigaku RINT-TTR diffractometer
(CuK, 50 kV, 300 mA)  and wide-angle XRD spectra were measured
on a Rigaku RINT2000/PC (FeK, 40 kV, 30 mA). Sample morpholo-
gies were examined by ﬁeld emission scanning electron microscopy
(FE-SEM; S-4300, Hitachi Co., Tokyo, Japan) with an accelerating
voltage of 10.0 kV. Before the FE-SEM observation, the samples
were coated with platinum using a Hitachi E-1020 ion sputtering
system (Hitachi High-Technologies Co., Tokyo, Japan). Transmis-
sion electron microscopy (TEM) images were acquired using JEOL
JEM 2010 electron microscope (JEOL Co., Tokyo, Japan) operating at
200 kV.
2.4. BPA antibody adsorption on MPS
MPS  material (10 mg)  was added to a solution of BPA antibody
(500 g) in 10 mM phosphate buffer (1 mL,  pH 7). This mixture was
kept at 4 ◦C for 12 h to allow the BPA antibody to adsorb on the MPS
surface and centrifuged at 3000 rpm for 5 min. A Bio-Rad Protein
Assay reagent (200 L) was  mixed with the supernatant (10 L)
for 20 min  at room temperature to determine the protein concen-
tration, as recommended by the supplier. The amount of adsorbed
antibody was measured by a spectrophotometric method using
bovine serum albumin as the standard.
2.5. BPA antibody–antigen reaction on MPS
MPS  (10 mg)  was added to a solution of BPA antibody (500 g)
in 10 mM phosphate buffer (1 mL,  pH 7). The mixture was kept at
4 ◦C for 12 h for BPA antibody adsorption. After solvent removal,
BPA (1 mL,  500 ng mL−1), used as an antigen, was added to the solid
and kept at 37 ◦C for 3 h (Fig. 1). The reaction mixture was  cen-Wakosil-II 5C18HG column (Wako Pure Chemicals, Osaka, Japan)
eluted with an acetonitrile–water mobile phase (8.0/2.0; v/v) at a
ﬂow rate of 0.15 mL min−1. The retention time of BPA was 16.7 min.
Each reported value was  the mean of at least three experiments.
T. Orita et al. / Journal of Asian Ceram
Fig. 1. Interactions between MPS-immobilised BPA antibody and BPA.
2
M
1
7
an 80% acetonitrile solution (1 mL)  in 10 mM phosphate buffer (pH
7) was  added to the MPS–BPA antibody–BPA composites to release
F
(.6. BPA recovery
To evaluate the solvent effects on BPA recovery rates, the
PS–BPA antibody–BPA composite was kept in 70%, 80%, 90% or
00% acetonitrile solution (1 mL)  in 10 mM phosphate buffer (pH
) at room temperature for 3 h to cleave the antigen–antibody
ig. 2. SEM images of the mesoporous silica materials: (a) MCM-41, (c) SBA-15-1, and (e)
b)  MCM-41, (d) SBA-15-1, and (f) SBA-15-2. Scale bar: 20 nm.ic Societies 2 (2014) 275–280 277
interactions. The recovered BPA was  measured through the pro-
cedure described in Section 2.5.
2.7. Recyclability of MPS immobilised BPA antibody
The reusability of immobilised antibodies is an important con-
sideration for industrial applications. To examine the residual
activity of BPA antibody, the procedures outlined in Section 2.5
were repeated up to three times using recovered MPS–BPA anti-
body composites.
2.8. BPA concentration
To enrich the BPA sample, a 50 ng mL−1 BPA solution was  ﬁrst
prepared. This BPA solution (1 mL)  was  mixed with the MPS–BPA
antibody composite and maintained at 37 ◦C for 3 h. This process
was repeated four times to increase the BPA concentration. NextBPA. The recovered BPA was  measured through the same procedure
as mentioned in Section 2.5.
 SBA-15-2. Scale bar: 500 nm.  TEM micrographs of the mesoporous silica materials:
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Sig. 3. (a) Nitrogen adsorption–desorption isotherms and (b) pore size distributions
f  MCM-41, SBA-15-1, and SBA-15-2.
. Results and discussion
.1. Characterisation of MPS
MPS  morphologies and structures were characterised through
EM, TEM and nitrogen (N2) adsorption/desorption analyses. Shape
s known to play an important role in the behaviour of MPS  beads as
rotein carriers [40]. SEM images showed that MCM  and SBA mate-
ials formed aggregated polyhedral particles with average particle
izes of 50 × 200 nm (MCM-41, Fig. 2a), 400 × 200 nm (SBA-15-
, Fig. 2c) and 1000 × 800 nm (SBA-15-2, Fig. 2e). TEM analysis
howed that the MPS  material displayed a high degree of structural
rder (Fig. 2). Surface area and average pore diameter are known
o impact the immobilisation and activity of supported antibod-
es. Therefore, N2 adsorption/desorption measurements (Fig. 3a)
ere performed for each MPS  and the Barrett–Joyner–Hallenda
odel (Fig. 3b) was applied to the adsorption isotherm for MCM-41,
BA-15-1, and SBA-15-2. This approach typically underestimates
he surface area, pore volume and diameter of mesopores but is
idely used. All of the isotherms were type IV curves. The isotherm
f MCM-41-1 indicated a reversible adsorption–desorption pro-
ess with a characteristic nitrogen condensation evaporation step
able 1
tructural properties of mesoporous silicates prepared in this manuscript.
Mesoporous silica Pore diametera (nm) Surface areab (m2 g−1) Pore
MCM-41 2.7 962 1.5 
SBA-15-1 12.3 757 2.0 
SBA-15-2 24.0 502 2.3 
a Calculated according to BJH analysis (adsorption branch between 1.7 and 300 nm dia
b Speciﬁc surface area according to BET.
c Determined by small-angle XRD [43–47].
d Average particle size is determined by SEM measurements.ic Societies 2 (2014) 275–280
at a relative pressure of ca. 0.3, and the volume adsorbed was
1.5 cm3 (STP) g−1. Meanwhile, the isotherms of SBA-15-1 and SBA-
15-2 exhibited the same step at relative pressures of ca. 0.75
and 0.84, with adsorbed volumes of 2.0 and 2.7 cm3 (STP) g−1,
respectively. Fig. 3b shows the pore size distribution curves of
synthesised MCM-41, SBA-15-1, and SBA-15-2. The curves of MCM-
41, SBA-15-1, and SBA-15-2 displayed sharp peaks at 2.7, 12.3,
and 24.0 nm,  respectively. Surface areas and pore volumes were
deduced using the BET model (Table 1). All the samples exhib-
ited relatively high surface areas (502–962 m2 g−1) and large pore
volumes (1.5–2.3 cm3 g−1). Moreover, pore sizes ranged from 2.7
to 24.0 nm,  indicating that the materials consisted of mesopores.
All the samples were synthesised according to the methods in our
previous reports [41] and XRD patterns of the products showed
similar proﬁles. The wide-angle XRD patterns of MCM-41 displayed
three reﬂection peaks corresponding to (1 0 0), (1 1 0) and (2 0 0)
planes, conﬁrming the presence of ordered hexagonal mesoporous
structures [41,42]. Small-angle XRD patterns showed three peaks
corresponding to the (1 0 0), (1 1 0) and (2 0 0) reﬂections of two-
dimensional hexagonal mesostructures for SBA-15-1 [43–45] but a
broad peak for SBA-15-2. This suggests that the addition of TMB  to
P123 formed a mesocellular silica foam [46].
3.2. Immobilisation study
3.2.1. BPA antibody adsorption on MPS and BPA binding activity
of the MPS-immobilised BPA antibody
Antibodies molecules are Y-shaped and consist of four polypep-
tide chains: two  identical heavy chains and two identical light
chains connected by disulphide bonds. The under part of the Y is
called fragment crystallisable (Fc fragment), which has a molecular
size of 3–5 nm.  The upper part of the Y is called fragment antigen
binding (Fab fragment), which has a molecular size of 9–11 nm and
recognises speciﬁc foreign objects [41,47]. The relative adsorbed
rate of BPA antibody was  determined for MCM-41 (2.7 nm), SBA-
15-1 (12.3 nm)  and SBA-15-2 (24.0 nm)  using the Bradford assay
(Fig. 4, solid bar). In this assay, MPS  (10 mg)  was added to a solution
of BPA antibody (500 g mL−1, 1 mL). The absorbance of BPA anti-
body (50 g) was assumed to be the adsorption rate of the antibody
100%. We analysed the amount of BPA antibody in the supernatant
and decided the relative adsorption rate. All MPSs adsorbed over
80% (40 g mg−1) of the BPA antibody. In the case of the MCM-41
(2.7 nm), the Fc fragment which has a molecular size of 3–5 nm,  ﬁt
into the pore. On the contrary, the Fab fragment which has a molec-
ular size of 9–11 nm absorbed inside the SBA-15-1 (12.3 nm)  and
SBA-15-2 (24.0 nm); therefore, the adsorption amount of antibod-
ies was a similar to three MPS.
Subsequently, the relative binding ratio between the MPS-
immobilised antibody and BPA was analysed (Fig. 4, open bar).
In this assay, MPS–BPA antibody composite (10 mg)  was  added to
a solution of BPA (500 ng mL−1, 1 mL). The HPLC peak height of
BPA (50 ng mL−1) was set as 100% binding activity. We  analysed
the amount of BPA in the supernatant by HPLC and decided the
relative binding rate. BPA amounts of 14, 17 and 16 ng adsorbed
on 1 mg  of MCM-41, SBA-15-1 and SBA-15-2-based MPS–antibody
 volumea (cm3 g−1) XRD patternsc Average particle sized (nm × nm)
2D-hexagonal 50 × 200
2D-hexagonal 400 × 200
Disordered 1000 × 800
meters).
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Fig. 4. Relative BPA antibody adsorption on MPS  and BPA binding activity of MPS-
immobilised BPA antibody.
Relative adsorption rate (%) = 100 × (absorbance of BPA antibody − absorbance of
unbound antibody in the supernatant)/absorbance of BPA antibody.
Relative binding rate (%) = 100 × (absorbance of unbound antigen in the supernatant
o
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tn  the MCM-41-BPA antigen system − absorbance of unbound antigen in the super-
atant on the MPS–BPA antibody–BPA antigen system)/absorbance of unbound
ntigen in the supernatant on the MCM-41–BPA antigen system.
omposites, respectively. Therefore, the immobilised antibody
xhibited BPA binding activities of 28%, 33% and 32% on MCM-
1, SBA-15-1 and SBA-15-2, respectively. These results indicate
hat MPS  pore size and morphology did not signiﬁcantly affect
he BPA antibody adsorption and binding activity of the resulting
PS–antibody composites.
.2.2. Effects of acetonitrile concentration on BPA recovery
Organic solvents strongly affect the BPA recovery rates of the
PA–MPS system. Therefore, the MPS–BPA antibody–BPA com-
osites were maintained in 70%, 80%, 90% and 100% acetonitrile
olutions in 10 mM phosphate buffer (pH 7). As shown in Fig. 5,
he 80% acetonitrile solution provided relative BPA recovery rates
f almost 100% for all the MPSs. Relative recovery rates were high
nly for MCM-41 (90%) and SBA-15-2 (100%) with 70% acetonitrile.
n contrast, for 90% and 100% acetonitrile solutions, these relative
ecovery rates decreased to 70–90%. Relative recovery rates were
ound to strongly depend on the acetonitrile concentration. The Fab
ragment in the BPA antibody displayed a greatly reduced activity
n 90% and 100% acetonitrile solutions compared to 70% and 80%
ig. 5. Relative BPA recovery rate at various acetonitrile concentrations.
elative recovery rate (%) = 100 × recovery amount of BPA antigen at various ace-
onitrile concentrations/binding amount of BPA antigen.Fig. 6. Residual BPA antibody activity on MPS  taken after several reuse cycles.
Relative activity (%) = 100 × recovery amount of BPA antigen after recycles/recovery
amount of BPA antigen before reuse.
solutions because its structure changed at high acetonitrile con-
centrations. Reactions were therefore performed under optimum
conditions (80% acetonitrile) in the following recyclability and BPA
enrichment experiments.
3.2.3. Effects of reuse on BPA antibody activity
The residual activity of the MPS-immobilised BPA antibody was
examined after multiple antigen binding–recovery cycles. Fig. 6
shows the residual activities of MPS–BPA antibody composites for
BPA after three recycles relative to the original activity before reuse
(taken as 100%). The residual activities after three recycles for SBA-
15-1 and SBA-15-2 amounted to 32% and 30%, respectively. BPA
antibody immobilised on MCM-41 displayed a lower residual activ-
ity (13%) after three recycles. It is understood that the immobilised
antibodies in the extremely large pores did not get easily deac-
tivated by the acetonitrile treatment because entire molecules of
antibodies absorbed inside the pores; therefore, the structural con-
formation of the antibody was  greatly stabilised.
3.2.4. Effect of MPS on the enrichment of BPA traces
To concentrate BPA, the antigen–antibody reaction was
repeated four times using 50 ng mL−1 BPA for a total adsorption
of 200 ng on the MPS–BPA antibody composites. Relative recov-
ery rates for SBA-15-1 and SBA-15-2 were equal to 82.4% (165 ng)
and 79.3% (159 ng), respectively (Fig. 7). On the other hand, the
rate was markedly reduced for MCM-41 (42.3%). These results
suggest that multiple soakings, separations and washing steps
involved in recycling easily strip the BPA antibody from MCM-41
pores, because only the Fc fragment of the antibody adsorbed on
Fig. 7. Relative recovery rate of concentrated BPA.
Relative recovery rate (%) = 100 × recovery amount of BPA antigen/total adsorption
amount of BPA antigen (200 ng).
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isting of larger pores, which resulted in a reduced relative recovery
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. Conclusions
Three types of MPS  – MCM-41 (2.7 nm), SBA-15-1 (12.3 nm)
nd SBA-15-2 (24.0 nm)  – were used for BPA binding exper-
ments. Investigations of BPA antibody immobilisation and
ntibody–antigen reaction showed that all MPSs adsorbed almost
he same amount of BPA antibody (approximately 80%) and exhib-
ted similar binding rates (approximately 30%). BPA recovery rates
rom 70%, 90% and 100% acetonitrile solutions were signiﬁcantly
educed, but were the highest when 80% acetonitrile was used.
fter three binding–recovery cycles, the immobilised BPA antibody
etained over 30% of its initial activity on SBA-15-1 and SBA-15-2.
his result indicated that entire antibody molecules were adsorbed
nside the pores, greatly stabilising their conformational orienta-
ion.
These ﬁndings open new and interesting prospects for ordered
esoporous materials, and provide important information on their
bility to detect and recover ultra-low concentration compounds in
icroanalysis systems.
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